About Magstim
Magstim is a company based in Whitland (United Kingdom) founded in 1990 was acquired by Telegraph Hill Partners in June 2015. Magstim has raised $32.05 million across 1 funding round from investors including Telegraph Hill Partners. The company has 87 employees. Magstim has completed 1 acquisition, including Electrical Geodesics. Magstim offers products and services including EEG Solutions, TMS Solutions, and tDCS Solutions. Magstim operates in a competitive market with competitors including Flow Neuroscience, NeuroStar, Soterix Medical, NeuroQore and Neuroprex, among others.
- Headquarter Whitland, United Kingdom
- Employees 87
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website magstim.com
- Social LinkedIn X Facebook Instagram YouTube
- Acquired by Telegraph Hill Partners (Jun 2015)
- Legal Name The Magstim Company Limited
- Date of Incorporation 24 Oct, 1988
- Jurisdiction WHITLAND, CARMARTHENSHIRE
- Annual Revenue$11.69 M (USD)-38as on Dec 31, 2023
- Net Profit-$2.17 M (USD)-286as on Dec 31, 2023
- EBITDA-$3.15 M (USD)-634as on Dec 31, 2023
- Total Equity Funding$32.05M (USD)
in 1 rounds
- Latest Funding Round$32.05M (USD), Unspecified
Oct 2015
- Investors
- Employee Count87
- Investments & Acquisitions
- Acquired byTelegraph Hill Partners
(Jun 2015)
Products & Services of Magstim
Magstim offers a comprehensive portfolio of products and services, including EEG Solutions, TMS Solutions, and tDCS Solutions.
Offers high-definition EEG systems for monitoring brain activity in research.
Provides transcranial magnetic stimulation devices for treating disorders.
Delivers portable transcranial direct current stimulation for therapy.
Funding Insights of Magstim
Magstim has successfully raised a total of $32.05M through 1 strategic funding round. The most recent funding activity was a Unspecified round of $32.05 million completed in October 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $32.05M
- Total Rounds 1
- Last Round Unspecified — $32.05M
- First Round $32.05M
(Oct 2015)
All 1 funding rounds of Magstim with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2015 | $32.05M | Unspecified | – | – | – |
1 investors in total: 1 institutional.
Investors in Magstim
Magstim has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Telegraph Hill Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm focused on life science, medical device and healthcare companies | – | thpartners.net | San Francisco, United States |
Investor details for Magstim
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Magstim
19 people are tracked at Magstim (6 in leadership, 13 in team); the tracked headcount is 87.
| Name | Role | Group |
|---|---|---|
Bill Necciai | Vice President North America Clinical Sales - Magstim TMS Therapy Systems | Leadership |
Gareth Davies | Director Of Operations & Site Leader | Leadership |
Lothar Krinke | CEO | Leadership |
Amy Banks | Marketing Director | Leadership |
Derin Rose | Uk/emea Director TMS Sales | Leadership |
John Leedham | Vice President Research And New Business Initiatives | Leadership |
Angharad Lewis | Sales Operations Manager | Team |
Millie Harry | Marketing Coordinator | Team |
Lyndi Bostic | Product Specialst Training Supervisor | Team |
Maheshram Madasamy | Business Development Manager | Team |
David Wilkinson | Divisional Quality Manager | Team |
Robert Rabinowitz | Field Sales Manager | Team |
Joseph Law | US Service Manager | Team |
Nicolas Hubacz | Research & Clinical Products Business Development Manager | Team |
Jamie Robertson | Product Service Support Specialist | Team |
Damian G. | Regional Business Development Manager | Team |
Andrea Nelson | Human Resources Manager | Team |
Dylan George | Quality Assurance Technician | Team |
Mike Casella | Consultant Validation Engineer | Team |
Complete people profiles for Magstim
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Magstim
Magstim has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Electrical Geodesics.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Non-invasive neurodiagnostic products are developed using dense array EEG technology. | egi.com | Eugene, United States | 1992 | Sep 2020 | •••• |
Complete acquisition details for Magstim
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Magstim
4 dated milestones of Magstim across 30 years, from founding to its latest funding, stage changes and deals.
- Founded Magstim is founded.
- Exit Acquired by Telegraph Hill Partners.
- Funding First funding round of $32.1M.
- Acquisition Acquires Electrical Geodesics.
Competitors of Magstim
Magstim operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Flow Neuroscience, NeuroStar, Soterix Medical, NeuroQore and Neuroprex, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| flowneuroscience.com | 2016 | Malmo, Sweden | $11.9M | – | Provider of a wearable device for stress and anxiety management | |
| neurostar.com | 2003 | Malvern, United States | $118.69M | 151 | Non-invasive TMS therapy is provided for major depressive disorder treatment. | |
| soterixmedical.com | 2008 | New York, United States | – | – | Non-invasive neuromodulation devices for mood disorders are manufactured. | |
| neuroqore.com | 2012 | Ottawa, Canada | $1.76M | – | Monophasic rTMS systems for depression treatment are developed by NeuroQore. | |
| neuroprexinc.com | 2012 | Santa Clara, United States | $50,000 | – | Wearable devices are developed to modulate tissues for neurological diseases. | |
| axilumrobotics.com | 2011 | Strasbourg, France | – | – | Developer of robot for assisting healthcare professionals | |
| magventure.com | 2007 | Farum, Denmark | – | – | Develops TMS machines for treating psychiatric disorders and conducting brain research. | |
| amperemedical.com.hk | 2018 | Kowloon, China | – | – | Develops innovative medical devices for brain treatment. | |
| tmsworkbook.com | 2018 | Nashville, United States | – | – | Digital platform for TMS therapy modules and patient assessments. |
Detailed competitors of Magstim
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Magstim
The website of Magstim (magstim.com) receives about 10.8K visits a month.
- Monthly visits10.8K
▼ 17.2% vs previous month
Websites whose visitors overlap most with Magstim. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| magventure.com | 100% | 10.9K | #2,194,059 | View details | |
philips.com.qa | philips.com.qa | 92% | – | #1,592,809 | – |
| carefusion.com | 82% | 5.9K | #3,234,823 | View details | |
somnomedics.de | somnomedics.de | 82% | – | #1,753,416 | – |
| cadwell.com | 78% | – | #967,375 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 22 similar websites and full traffic analytics for Magstim
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 22 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Magstim
Complete news archive for Magstim
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Magstim
10 companies that operate in the same segment as Magstim (Neurology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Novel biopharmaceutical medicines are developed for unmet medical needs. | 2003 | Dublin, Ireland | USD 265 M | USD 4.27 B | 2,800 | |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Developer of therapeutics for psychiatric and neurologic diseases | 2002 | New York, New York, United States | USD 80.87 M | USD 250.31 M | 600 | |
Biologics platform developed for intracellular delivery in rare diseases. | 2016 | Boston, Massachusetts, United States | USD 175.25 M | USD 25.42 M | 183 | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
MR-interfaced ultrasound devices for cancer and neurology treatments are provided. | 1999 | Tirat Carmel, Haifa District, Israel | USD 574.2 M | – | – | |
AI-driven drug discovery platform for neurological diseases based on patients biomarkers | 2019 | San Francisco, California, United States | USD 144.72 M | – | 76 | |
Small molecule drugs for rare diseases are developed. | 1998 | South Plainfield, New Jersey, United States | USD 248.1 M | USD 1.73 B | 939 | |
Developer of small molecule therapeutics for endocrine and CNS disorders | 1992 | San Diego, California, United States | USD 10 M | USD 2.86 B | 1,800 | |
Developer of antibodies to treat complement-mediated neurodegenerative diseases | 2011 | San Francisco, California, United States | USD 256 M | – | 100 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Magstim
Magstim was founded in 1990 and raised its 1st funding round 25 years after it was founded.
Magstim is headquartered in Whitland, United Kingdom. It is registered at Whitland, Carmarthenshire, United Kingdom.
Magstim is a funded company, having raised a total of $32.05M across 1 funding round to date. The company's 1st funding round was a Unspecified of $32.05M, raised on Oct 2015.
Magstim has 87 employees.
Annual revenue of Magstim is $11.69M as on Dec 31, 2023.
Founded in 1990 and headquartered in Whitland, United Kingdom, neurotechnology systems focused on EEG, TMS, and tDCS are provided by the company. Integrated solutions, sensors, and portable devices are offered for research and clinical applications in brain condition studies and treatments. Support and resources are extended to researchers and clinicians across various sectors.
Magstim's top competitors include NeuroStar, Flow Neuroscience and Neuroprex.
Magstim offers EEG Solutions, TMS Solutions, and tDCS Solutions.
Magstim has made 1 acquisition, including Electrical Geodesics.
Magstim has 1 investor. Key investors include Telegraph Hill Partners.
Magstim operates through The Magstim Company Limited.
Yes. Magstim was acquired by Telegraph Hill Partners in June 2015.